"Marburg diagnostics the key" against lethal Angolan virus
This article was originally published in Clinica
The United Nations has highlighted a need for "exceptionally precise diagnostics" to tackle the outbreak of Marburg haemorrhagic disease in Angola, amid fears that it might rapidly spread beyond its borders. Last week, the UN launched a $3.5m appeal to support work on this rare but highly lethal disease, saying that early diagnosis and isolation were vital. With a 90% fatality rate, Marburg ranks with the closely-related Ebola fever as being among the most lethal known to humans.
You may also be interested in...
A reagent in a batch of COVID-19 tests shipped by the US Centers for Disease Control and Prevention to state laboratories “wasn’t performing consistently,” a top CDC official says, so the agency is reformulating it – slowing down the labs’ ability to use the diagnostic, which yielded inconsistent results when quality-tested. But waiting in the wings are commercial coronavirus test kits being developed by Qiagen and Cepheid; both firms say they’ll submit the kits to the FDA for emergency-use approval.
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.